Advanced Practice Provider Onboarding: An Academic Teaching Institution's Experience.

J Nurs Adm

Author Affiliations: Manager of Advanced Practice Professional Development (Koppolu), Center for Advanced Practice, Stanford Medicine Children's Health, Palo Alto; and Manager of Advanced Practice Providers (Dr Nandwani and Navoa) and Executive Director of Advanced Practice (Kuriakose), Center for Advanced Practice, Stanford Medicine Health Care, Stanford, California.

Published: June 2023

With the robust growth in demand for advanced practice providers (APPs), employers must focus on strategies to promote recruitment, retention, and job satisfaction. The authors describe the creation, development, and sustainability of an APP onboarding program to support the initial transition for providers into their new roles within an academic healthcare organization. Advanced practice provider leaders coordinate with multidisciplinary stakeholders to ensure new-hire APPs are equipped with the necessary tools for a successful start.

Download full-text PDF

Source
http://dx.doi.org/10.1097/NNA.0000000000001292DOI Listing

Publication Analysis

Top Keywords

advanced practice
12
practice provider
8
provider onboarding
4
onboarding academic
4
academic teaching
4
teaching institution's
4
institution's experience
4
experience robust
4
robust growth
4
growth demand
4

Similar Publications

Hypertension, commonly known as high blood pressure, is a significant health issue that increases the risk of cardiovascular diseases, stroke, and renal failure. This condition broadly encompasses both primary and secondary forms. Despite extensive research, the underlying mechanisms of systemic arterial hypertension-particularly primary hypertension, which has no identifiable cause and is affected by genetic and lifestyle agents-remain complex and not fully understood.

View Article and Find Full Text PDF

Context.—: Generative artificial intelligence (AI) has emerged as a transformative force in various fields, including anatomic pathology, where it offers the potential to significantly enhance diagnostic accuracy, workflow efficiency, and research capabilities.

Objective.

View Article and Find Full Text PDF

Splenomegaly is a quite common clinical feature of Philadelphia (Ph) negative chronic myeloproliferative neoplasms (MPNs) and its presence may, in some cases, drives treatment decision. Most importantly, palpable splenomegaly is a minor criterion for both pre-fibrotic/early primary myelofibrosis and primary myelofibrosis (PMF) diagnosis, even if clinical assessment by physical examination is poorly reliable and accurate. On the other hand, despite the International Working Group-Myeloproliferative Neoplasms Research and Treatment and European LeukemiaNet guidelines defined spleen response criteria by palpation, they also recognized the highly subjective nature of spleen size assessment by physical examination, and recommended objective confirmation of volume reduction via computed tomography or magnetic resonance imaging (MRI).

View Article and Find Full Text PDF

exon 14 ex14) skipping occurs in 3-4% of non-small-cell lung cancer (NSCLC) cases. Low frequency of this alteration necessitated open-label, single-arm trials to investigate MET inhibitors. Since broad MET biomarker testing was only recently introduced in many countries, there is a lack of historical real-world data from patients with ex14 skipping NSCLC receiving conventional therapies.

View Article and Find Full Text PDF

Suggesting a Doctor of Nursing Practice Degree With a Specialization in Wound Care Filling a Gap in Advanced Practice Nursing: A View Here.

J Wound Ostomy Continence Nurs

January 2025

Tim Porter O'Grady, DM, EdD, APRN, CWCN, CFCN, FAAN, FACCWS, Health Systems, TPOG Associates, LLC, Atlanta, Phoenix, and Emory University, Nell Hodgson Woodruff School of Nursing, Atlanta, Georgia.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!